9,10-Dihydro-1,8,9-trihydroxy-9,10-anthracene .alpha.,.beta.-end

Details 9,10-Dihydro-1,8,9-trihydroxy-9,10-anthracene .alpha.,.beta.-end 9,10-Dihydro-1,8,9-trihydroxy-9,10-anthracene .alpha.,.beta.-end

1982-06-29

1984-08-14

Daus, Donald G.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Fungus, except allergen, or component thereof or substance...

548419, 560 56, 562466, C07D20740, C07D207404, A61K 3140

Patent

active

044656882

ABSTRACT:
The invention concerns adducts of 1,8-dihydroxy-9-anthrone, of formula: ##STR1## in which: R.sub.1 and R.sub.2, taken together, form one of the following divalent residues: ##STR2## R.sub.3, R.sub.4, R'.sub.4, R.sub.5 and R'.sub.5 representing H, an alkyl group having 1-8 C with the exception of R.sub.5 =R'.sub.5 =CH.sub.3, a monohydroxyalkyl group with 2-8 C, possibly interrupted by one or more oxygens, a cycloalkyl group having 4-6 C, a phenyl group, or a benzyl group.
Utilization of the compounds (I) in human or veterinary medicine, in particular in the treatment of psoriasis and or warts, and in cosmetics.

REFERENCES:
patent: 3123618 (1964-03-01), Schumann et al.
patent: 3678072 (1972-07-01), Klanderman et al.
The Merk Index, 9th Ed. Merk & Co., Inc. N.J. (1976) p. 452 at 3394.
Schultz et al., Chem. Abstracts 88:104985h (1978).

Affiliated with

Also associated with

Rating

9,10-Dihydro-1,8,9-trihydroxy-9,10-anthracene .alpha.,.beta.-end does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 9,10-Dihydro-1,8,9-trihydroxy-9,10-anthracene .alpha.,.beta.-end, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 9,10-Dihydro-1,8,9-trihydroxy-9,10-anthracene .alpha.,.beta.-end will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-114021